LINCOLN
Invest Now
Lincoln Pharmaceuticals Share Price
₹616.00 -7.45 (-1.19%)
21 Nov, 2024 14:04
Start SIP in LINCOLN
Start SIPPerformance
- Low
- ₹612
- High
- ₹625
- 52 Week Low
- ₹535
- 52 Week High
- ₹812
- Open Price₹625
- Previous Close₹623
- Volume23,018
Investment Returns
- Over 1 Month -7.01%
- Over 3 Month -11.92%
- Over 6 Month + 6.92%
- Over 1 Year + 2.37%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12.8
- PEG Ratio
- 0.7
- Market Cap Cr
- 1,234
- P/B Ratio
- 2.1
- Average True Range
- 23.4
- EPS
- 48.25
- Dividend Yield
- 0.3
- MACD Signal
- -9.45
- RSI
- 35.62
- MFI
- 24.75
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹616.00
-7.45
(-1.19%)
- Bullish Moving Average 0
- Bearish Moving Average 16
- 20 Day
- ₹653.79
- 50 Day
- ₹669.36
- 100 Day
- ₹666.47
- 200 Day
- ₹640.58
Resistance and Support
621.02
- R3 649.68
- R2 639.32
- R1 631.38
- S1 613.08
- S2 602.72
- S3 594.78
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-08 | Quarterly Results | |
2024-05-16 | Audited Results & Final Dividend | |
2024-02-08 | Quarterly Results | |
2023-11-02 | Quarterly Results |
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹616 As on 21 November, 2024 | 13:50
The Market Cap of Lincoln Pharmaceuticals is ₹1233.8 Cr As on 21 November, 2024 | 13:50
The P/E ratio of Lincoln Pharmaceuticals is 12.8 As on 21 November, 2024 | 13:50
The PB ratio of Lincoln Pharmaceuticals is 2.1 As on 21 November, 2024 | 13:50
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.